Physician profile
Erika Kettelhut
NPI 1679012868
$11,892.19
in general payments reported to CMS, 2019-2025
33 companies · $2,036 in 2025
The $2,036 reported for 2025 was more than what 76% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,655 · 2020: $740 · 2021: $295 · 2022: $1,847 · 2023: $2,412 · 2024: $2,908 · 2025: $2,036.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,775 · Education: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,775.38 |
| Education | $580.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,770.11 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $1,610.82 | 2019-2025 | Absorica Ld, Winlevi, Ilumya |
| Regeneron Healthcare Solutions, INC. | $943.54 | 2019-2025 | Dupixent, Libtayo |
| Janssen Biotech, INC. | $878.49 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Novartis Pharmaceuticals Corporation | $839.29 | 2019-2025 | |
| Amgen INC. | $821.29 | 2019-2025 | Otezla, Otezla |
| Lilly USA, LLC | $642.34 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Incyte Corporation | $575.97 | 2021-2025 | Opzelura |
| Genzyme Corporation | $407.37 | 2019-2025 | |
| Pfizer INC. | $398.34 | 2019-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $328.56 | 2019-2025 | Cabtreo, Siliq, Jublia |
| Galderma Laboratories, L.P. | $244.25 | 2022-2025 | Nemluvio, Aklief |
| Dermavant Sciences, INC. | $209.25 | 2022-2024 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $205.20 | 2022-2025 | Sotyktu |
| Ucb, INC. | $191.84 | 2023-2025 | Bimzelx, Cimzia |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $127.44 | 2021-2025 | Adbry, Spevigo |
| Sanofi-Aventis U.S. LLC | $99.99 | 2020 | |
| Arcutis Biotherapeutics, INC. | $95.00 | 2023-2025 | Zoryve |
| Strata Skin Sciences, INC. | $71.78 | 2023-2024 | Xtrac |
| Almirall LLC | $70.82 | 2019-2023 | Seysara, Klisyri |
| Epi Health, LLC | $54.45 | 2019-2022 | |
| Lnhc, INC | $45.46 | 2025 | Zelsuvmi |
| Mimedx Group, INC. | $42.22 | 2024 | |
| Celgene Corporation | $39.40 | 2019 | |
| Organon LLC | $31.32 | 2025 | |
| Verrica Pharmaceuticals INC. | $23.66 | 2024 | Ycanth |
| Krystal Biotech INC | $22.04 | 2024 | Vyjuvek |
| Convatec INC. | $21.27 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.89 | 2023 | Spevigo |
| Aclaris Therapeutics, INC. | $18.50 | 2019 | |
| Dermira, INC. | $15.58 | 2020 | |
| Paratek Pharmaceuticals, INC. | $13.06 | 2022 | |
| Vyne Pharmaceuticals INC. | $12.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Kettelhut listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.